Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. (Q53885278)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. |
scientific article |
Statements
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. (English)
1 reference
G Ritter
1 reference
L J Old
1 reference
A M Scott
1 reference
F T Lee
1 reference
W Hopkins
1 reference
J S Cebon
1 reference
J M Wheatley
1 reference
Z Liu
1 reference
F E Smyth
1 reference
C Murone
1 reference
S Sturrock
1 reference
D MacGregor
1 reference
N Hanai
1 reference
K Inoue
1 reference
M Yamasaki
1 reference
M W Brechbiel
1 reference
I D Davis
1 reference
R Murphy
1 reference
A Hannah
1 reference
M Lim-Joon
1 reference
T Chan
1 reference
G Chong
1 reference
E W Hoffman
1 reference
A W Burgess
1 reference
1 October 2001
1 reference
19
1 reference
19
1 reference
3976-3987
1 reference
Identifiers
1 reference